NLS Bio-Me

Bio-Me has employed Dr. Anne-Grethe Reichelt as International Sales and BD Manager. This step is part of the company’s plan to widen commercial adoption of their existing product portfolio as well as launching new products under development, it states. Anne-Grethe will report to Chief Business Officer Runar Vige. “This is a milestone hire for Bio-Me: […]

Bio-Me has announced that Heiner Dreissman and Charles Stabell have been appointed as senior advisors. These steps are part of the company’s strategic plan to position Bio-Me as a leader in the field with its Precision Microbiome Profiling (PMP) platform which offers a targeted approach to microbiome analysis/profiling using state-of-the-art qPCR and are in advance […]

Bio-Me has announced that Warren Flood has become CEO following a successful period as COO. Previous CEO, Morten Isaksen, moves up to the Board and will also continue as Chief Innovation Officer with a focus on longer term and higher value clinical applications for the company’s Precision Microbiome Profiling (PMP) technology, states the company. “We […]

Bio-Me has raised NOK 10 million in a fully subscribed funding round. Both existing and new investors participated in the financing round, with new investors contributing the majority of the capital, states the company in a press release. “We are excited to move forward with our plans to achieve specific value-driving milestones that position PMP […]

Microbiome Dx company Bio-Me and Siolta Therapeutics have entered into a collaboration and marketing agreement. Under the agreement, Siolta will provide both samples and insights into key criteria for Bio-Me to develop a rapid, detailed and comprehensive diagnostic test for infants at risk of developing allergy and asthma, they state. The test will be offered […]